Mediprobe Research has the in-house capability and expertise to take your Phase II-IV Clinical Trial right from development through to statistical analysis and final report writing.

> Study design, protocol/information consent preperation, case report form and database development
> Regulatory submission for initial and ongoing approval to a central IRB, (REB), Health Canada (TPD), FDA
> Clinical trial coordinators with in-house phlebotomy/ processing and shipping of blood samples
> Experienced data management group to produce reports/manuscripts/other medical literature

Mediprobe Research, and its' sister companies, Acclaim Pharma Research and AG Pharma, are able to provide complimentary and a complete service cycle, from the development of new dermatological products, to basic in-vitro laboratory research and onwards to Phase II-IV trials, we help bring products to market.

Acclaim Pharma Research is a contract research organization for bioequivalence studies with generic products and Phase I clinical first-in-man trials (www.acclaimpharma.com).

AG Pharma builds strategic alliances with pharmaceutical companies to co-develop their topical or oral products leading to marketing.

Mediprobe's other sister company, Avail Cosmetics and Laser MediCentre, offers laser/intense pulsed light aesthetics, Botox, fillers, facial peels and other cosmetic enhancements to our clients. We offer management options for skin conditions such as rosacea, lentigines, photodamage, excessive hair growth and excessive sweating. Regarding cosmetics and laser/intense pulsed light therapy, visit us at www.availcosmetics.com.